|
Viral oncoproteins: Revealing novel structural motifs to target tumor suppressors
|
5R01CA178932-05
|
$402,550
|
|
O'SHEA, CLODAGH
|
SALK INSTITUTE FOR BIOLOGICAL STUDIES
|
|
Viral Modulation of Genetic Stability
|
5R01CA097093-15
|
$399,000
|
|
WEITZMAN, MATTHEW
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Understanding optimal delivery systems for cancer care
|
5R01CA174768-05
|
$380,646
|
|
MILLER, DAVID
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Transmembrane Proteins Involved in Human Tumor Expansion
|
5R01CA105412-14
|
$423,800
|
|
QUIGLEY, JAMES
|
SCRIPPS RESEARCH INSTITUTE
|
|
Translational regulation of the breast cancer stem cell by eIF4G1
|
5R01CA178509-04
|
$405,600
|
|
SCHNEIDER, ROBERT
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Training in Cancer Biology
|
5T32CA009547-33
|
$535,845
|
|
SCHREIBER, ROBERT
|
WASHINGTON UNIVERSITY
|
|
Towards The Chemotherapy-Free Treatment of Follicular Lymphoma
|
5R01CA183876-05
|
$475,801
|
|
WENDEL, HANS-GUIDO
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Topology of Cancer Evolution and Heterogeneity
|
5U54CA193313-04
|
$2,030,348
|
|
RABADAN, RAUL
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
TMAO, the Gut Microbiome, and Colorectal Cancer Risk in the Multiethnic Cohort
|
5R01CA204368-03
|
$319,624
|
|
LIM, UNHEE
|
UNIVERSITY OF HAWAII AT MANOA
|
|
Therapeutic Targeting Agents for Ovarian Cancer
|
5R01CA115483-14
|
$345,281
|
|
LAM, KIT
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
The role of wild-type KRAS in the context of tumor profession and metastasis
|
5R01CA178445-04
|
$450,563
|
|
SU, GLORIA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
The role of the LZTR1 ubiquitin ligase in stem cells and cancer
|
5R01CA190891-04
|
$383,079
|
|
IAVARONE, ANTONIO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
The role of MDM2-MTBP axis in cancer metastasis
|
5R01CA174735-05
|
$313,325
|
|
IWAKUMA, TOMOO
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
|
The role of genetic susceptibility in melanoma development
|
5R01CA182890-05
|
$404,587
|
|
HERLYN, MEENHARD
|
WISTAR INSTITUTE
|
|
The role of EGFR as a mechanism of therapeutic resistance in gene fusion positive lung cancer.
|
5R01CA193935-03
|
$422,586
|
|
DOEBELE, ROBERT
|
UNIVERSITY OF COLORADO DENVER
|
|
The NYU Womens Health Study
|
5UM1CA182934-04
|
$701,162
|
|
ZELENIUCH-JAQUOTTE, ANNE
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
The Johns Hopkins Center for AIDS Research (JHU CFAR)
|
5P30AI094189-07
|
$358,971
|
|
CHAISSON, RICHARD
|
JOHNS HOPKINS UNIVERSITY
|
|
The Hippo/Yap Signaling Pathway In Ovarian High Grade Serous Carcinoma
|
5R01CA197976-04
|
$376,067
|
|
WANG, CHENG
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
The aberrant androgen receptor underlies abiraterone/enzalutamide resistance
|
5R01CA185297-04
|
$370,575
|
|
LUO, JUN
|
JOHNS HOPKINS UNIVERSITY
|
|
TGFB-SMAD Signaling in Stem Cell Differentiation and Tumor Suppression
|
5R01CA034610-36
|
$468,594
|
|
MASSAGUE, JOAN
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Targeting NEDD8-Mediated Protein Turnover in AML
|
5R01CA172443-05
|
$286,661
|
|
CAREW, JENNIFER
|
UNIVERSITY OF ARIZONA
|
|
Targeting extracellular matrix-cancer stem cell interactions in pancreatic cancer
|
5R01CA193887-03
|
$45,933
|
|
MATSUI, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Systems Bioengineering of Cancer Cell Migration
|
5R01CA196018-04
|
$449,826
|
|
LUKER, GARY
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Systematic dissection of an aberrant splicing program driving cancer metastasis
|
5R00CA194077-04
|
$248,297
|
|
GOODARZI, HANI
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Substrate Specificity of Non-receptor Tyrosine Kinases
|
5R01CA058530-23
|
$244,478
|
|
MILLER, W
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
Studies of Rare Cancers
|
ZIA CP010158-01093
|
$342,780
|
$34,278
|
A Brinton, Louise
|
DCEG (NCI)
|
|
Studies of Rare Cancers
|
ZIA CP010158-01135
|
$15,968
|
$1,597
|
A Brinton, Louise
|
DCEG (NCI)
|
|
Studies of Populations Exposed to Occupational Sources of Radiation
|
ZIA CP010133-04101
|
$5,043
|
$252
|
S Linet, Martha
|
DCEG (NCI)
|
|
Structured Light Scatteroscopy for Intraoperative Breast Tumor Margin Assessment
|
5F31CA196308-03
|
$6,154
|
|
MCCLATCHY III, DAVID
|
DARTMOUTH COLLEGE
|
|
Structural & Programmatic Effects of Bus Rapid Transit on Physical Activity
|
5R01CA178343-05
|
$238,241
|
|
SAELENS, BRIAN
|
SEATTLE CHILDREN'S HOSPITAL
|
|
Spatio-Temporal Organization of Chromatin and Information Transfer in Cancer
|
5U54CA193419-04
|
$2,095,133
|
|
O'HALLORAN, THOMAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
SOX9 Mediation of AR and ERG Driven Prostate Cancer
|
5R01CA168393-05
|
$361,050
|
|
BALK, STEVEN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Small Molecule PSMA-Targeted Alpha Therapy
|
5R01CA184228-05
|
$401,678
|
|
POMPER, MARTIN
|
JOHNS HOPKINS UNIVERSITY
|
|
Shanghai prospective cohort study of occupational exposures and cancer risk among
|
ZIA CP010123-02342
|
$684,129
|
$20,524
|
Chow
|
DCEG (NCI)
|
|
SEQUENCE-SPECIFIC CHROMATIN MODIFIERS; NOVEL PROTEIN THERAPEUTICS FOR B CELL LYMPHOMA
|
5R01CA188286-04
|
$348,844
|
|
PAYTON, JACQUELINE
|
WASHINGTON UNIVERSITY
|
|
Selective Targeting Survivin for Cancer Therapy
|
5R01CA193609-03
|
$380,127
|
|
LI, WEI
|
UNIVERSITY OF TENNESSEE HEALTH SCI CTR
|
|
Roles of miR-129 in colorecal cancer
|
5R01CA197098-03
|
$359,202
|
|
JU, JINGFANG
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
Role of SOD1 in cancer
|
5R01CA172046-05
|
$351,713
|
|
GERMAIN, DORIS
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
Role of multiple myeloma cancer stem cells in clinical disease
|
5R01CA174951-05
|
$580,232
|
|
HUFF, CAROL
|
JOHNS HOPKINS UNIVERSITY
|
|
Role of c-Cbl in Colon cancer
|
5R01CA175382-05
|
$361,050
|
|
CHITALIA, VIPUL
|
BOSTON MEDICAL CENTER
|
|
Role of autophagy in tumor cell death
|
5R01CA150925-09
|
$388,602
|
|
THORBURN, ANDREW
|
UNIVERSITY OF COLORADO DENVER
|
|
RNA Therapeutics for Targeted Treatment of Colon Cancer
|
5R01CA186100-05
|
$342,809
|
|
GUO, BIN
|
UNIVERSITY OF HOUSTON
|
|
RIP1/3 Kinases as New Targets in Malignant Mesothelioma
|
5R01CA190542-04
|
$423,359
|
|
TESTA, JOSEPH
|
RESEARCH INST OF FOX CHASE CAN CTR
|
|
Research Training in Academic Medical Oncology
|
5T32CA009666-24
|
$509,745
|
|
DAVIES, MICHAEL
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Regulation of transcription and tumor suppression by MTG family members
|
5R01CA178030-05
|
$364,000
|
|
HIEBERT, SCOTT
|
VANDERBILT UNIVERSITY
|
|
Regulation of cell growth and proliferation by Myc
|
5R01CA020525-42
|
$555,771
|
|
EISENMAN, ROBERT
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Reactivation of embryonic growth programs in liver cancer
|
5R01CA190525-04
|
$370,575
|
|
ZHU, HAO
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Rac1 GTPase in tumorigenesis and progression of pancreatic cancer
|
5R01CA206444-03
|
$374,745
|
|
OUELLETTE, MICHEL
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
Quantitative Imaging of Cancer Drug Resistance via Radioluminescence Microarrays
|
5R01CA186275-05
|
$333,421
|
|
PRATX, GUILLEM
|
STANFORD UNIVERSITY
|
|
Quantitative assessment of the role of collagen alterations in ovarian cancer
|
5R01CA206561-03
|
$389,549
|
|
CAMPAGNOLA, PAUL
|
UNIVERSITY OF WISCONSIN-MADISON
|
Total relevant funding to Alcoholism Research for this search: $612,111
|